A Pre-Formulation Study for Delivering Nucleic Acids as a Possible Gene Therapy Approach for Spinocerebellar Ataxia...

Area of Science:

• Biotechnology
• Nanomedicine
• Neuroscience

Background:

• Liposomes are biocompatible lipid vesicles with tunable properties for drug delivery.
• Gene therapy holds promise for treating genetic disorders, but efficient delivery systems are needed.

Purpose of the Study:

• To develop liposomes for effective nucleic acid delivery to neuronal cells.
• To lay the groundwork for CRISPR/Cas9 gene editing in neurodegenerative diseases.

Main Methods:

• Liposomes with various lipid compositions were synthesized using the ethanol injection method.
• Formulations were analyzed for size, stability, and DNA interaction.
• In vitro studies used a neuroblastoma cell line (SH-SY5Y) to assess transfection efficiency and toxicity.

Main Results:

• A specific liposome formulation (phosphatidylcholine, phosphatidylethanolamine, pegylated lipid, cholesterol, cationic lipid at 1:2:4:2:2 molar ratio) showed high mRNA delivery efficiency.
• The selected liposomes demonstrated good interaction with DNA and successful transfection of neuronal cells.

Conclusions:

• Optimized liposomes show potential as effective nanosystems for neuronal gene delivery.
• This study is a critical preclinical step towards developing CRISPR/Cas9-based therapies for autosomal dominant neurodegenerative disorders.